Inmazeb Side Effects
Generic name: atoltivimab / maftivimab / odesivimab
Medically reviewed by Drugs.com. Last updated on Dec 14, 2023.
Note: This document contains side effect information about atoltivimab / maftivimab / odesivimab. Some dosage forms listed on this page may not apply to the brand name Inmazeb.
Applies to atoltivimab / maftivimab / odesivimab: parenteral concentrate for iv infusion.
Side effects include:
Most common adverse reactions (≥20%) are pyrexia, chills, tachycardia, tachypnea, vomiting.
More about Inmazeb (atoltivimab / maftivimab / odesivimab)
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.